Quality & complianceOfficial

Greek regulator EOF extends recall of Pedmarqsi 80 mg/ml infusion to three more batches

🇬🇷 EOF · Fri 06 Nov 2026

EOF has issued a supplementary recall covering batches 489588, 493006 and 497199 of Pedmarqsi 80 mg/ml solution for infusion, adding to an earlier recall.

The Greek National Organisation for Medicines (EOF) has issued a supplementary recall of three batches of Pedmarqsi 80 mg/ml, a solution for infusion. The batches are 489588, 493006 and 497199.

The notice carries protocol number 136391 and is dated 6 November 2026. Its title describes it as supplementary, so it adds to an earlier recall of the same product rather than starting a new action.

The published item is only a short listing that links to the full EOF decision. It does not state why the batches are being recalled, what defect or risk is involved, or what steps pharmacies, wholesalers and hospitals must take. It also does not say whether the recall reaches patient level or stops at distribution.

Readers should consult the full decision on the EOF website for the reason, the scope and the required actions.

What it means for your team

  • Check whether batches 489588, 493006 or 497199 of Pedmarqsi 80 mg/ml are held in Greek distribution or hospital stock, and quarantine any that are found.
  • Read the full EOF decision (protocol 136391) for the recall reason and the instructions for returning stock, as the summary does not give them.
  • Compare the supplementary batches with those in the earlier recall, so that stock reconciliation covers every affected lot.
  • Marketing authorisation holders and distributors should check whether their own recall and communication procedures apply.

Official source: EOF ↗

Article written by VigiEye from the official source (EOF). AI-assisted; check the source before acting.

More Quality & compliance All →